Prendergast GC - Search Results

1

Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'.

Prendergast GC, Mondal A, Dey S, Laury-Kleintop LD, Muller AJ. Prendergast GC, et al. Trends Cancer. 2018 Jan;4(1):38-58. doi: 10.1016/j.trecan.2017.11.005. Epub 2017 Dec 21. Trends Cancer. 2018. PMID: 29413421 Free PMC article. Review.

2

Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.

DuHadaway JB, Du W, Donover S, Baker J, Liu AX, Sharp DM, Muller AJ, Prendergast GC. DuHadaway JB, et al. Among authors: prendergast gc. Oncogene. 2003 Jun 5;22(23):3578-88. doi: 10.1038/sj.onc.1206481. Oncogene. 2003. PMID: 12789266

3

Targeted deletion of the suppressor gene bin1/amphiphysin2 accentuates the neoplastic character of transformed mouse fibroblasts.

Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Muller AJ, et al. Among authors: prendergast gc. Cancer Biol Ther. 2004 Dec;3(12):1236-42. doi: 10.4161/cbt.3.12.1232. Epub 2004 Dec 14. Cancer Biol Ther. 2004. PMID: 15611650

4

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Muller AJ, et al. Among authors: prendergast gc. Nat Med. 2005 Mar;11(3):312-9. doi: 10.1038/nm1196. Epub 2005 Feb 13. Nat Med. 2005. PMID: 15711557

5

Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.

Muller AJ, Malachowski WP, Prendergast GC. Muller AJ, et al. Among authors: prendergast gc. Expert Opin Ther Targets. 2005 Aug;9(4):831-49. doi: 10.1517/14728222.9.4.831. Expert Opin Ther Targets. 2005. PMID: 16083346 Review.

6

Marrying immunotherapy with chemotherapy: why say IDO?

Muller AJ, Prendergast GC. Muller AJ, et al. Among authors: prendergast gc. Cancer Res. 2005 Sep 15;65(18):8065-8. doi: 10.1158/0008-5472.CAN-05-2213. Cancer Res. 2005. PMID: 16166276 Review.

7

Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.

Gaspari P, Banerjee T, Malachowski WP, Muller AJ, Prendergast GC, DuHadaway J, Bennett S, Donovan AM. Gaspari P, et al. Among authors: prendergast gc. J Med Chem. 2006 Jan 26;49(2):684-92. doi: 10.1021/jm0508888. J Med Chem. 2006. PMID: 16420054 Free PMC article.

8

Bin1 ablation in mammary gland delays tissue remodeling and drives cancer progression.

Chang MY, Boulden J, Sutanto-Ward E, Duhadaway JB, Soler AP, Muller AJ, Prendergast GC. Chang MY, et al. Among authors: prendergast gc. Cancer Res. 2007 Jan 1;67(1):100-7. doi: 10.1158/0008-5472.CAN-06-2742. Cancer Res. 2007. PMID: 17210688

9

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.

Hou DY, Muller AJ, Sharma MD, DuHadaway J, Banerjee T, Johnson M, Mellor AL, Prendergast GC, Munn DH. Hou DY, et al. Among authors: prendergast gc. Cancer Res. 2007 Jan 15;67(2):792-801. doi: 10.1158/0008-5472.CAN-06-2925. Cancer Res. 2007. PMID: 17234791

10

Indoleamine 2,3-dioxygenase in immune suppression and cancer.

Muller AJ, Prendergast GC. Muller AJ, et al. Among authors: prendergast gc. Curr Cancer Drug Targets. 2007 Feb;7(1):31-40. doi: 10.2174/156800907780006896. Curr Cancer Drug Targets. 2007. PMID: 17305476 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page